Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 May;91(1):229–235. doi: 10.1111/j.1476-5381.1987.tb09003.x

Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate.

A Bennett, J D Gaffen, P B Melhuish, I F Stamford
PMCID: PMC1853484  PMID: 3594078

Abstract

The effect of indomethacin on the response of the NC carcinoma to methotrexate has been examined in vivo and in vitro. Survival was prolonged in mice treated with indomethacin 1.25 mg kg-1 twice daily plus methotrexate 4 mg kg-1 daily, compared to mice given either drug alone or controls. Indomethacin 1 microgram ml-1 increased the killing of cultured NC cells by methotrexate. This was not due to displacement of methotrexate from binding sites on the serum proteins. Nor was it due (entirely) to inhibition of prostaglandin synthesis, since flurbiprofen did not mimic the effect. Inhibition of cyclic AMP phosphodiesterase seems unlikely to explain the effect of indomethacin since theophylline had little or no effect on NC cell killing by methotrexate. Indomethacin 1 microgram ml-1 increased the accumulation of tritium in NC cells incubated with [3H]-methotrexate. In contrast, with normal epithelial cells from human embryonic intestine, indomethacin 1 microgram ml-1 did not alter the cytotoxicity of methotrexate or the accumulation of tritium during incubation with [3H]-methotrexate. The beneficial interaction between indomethacin and methotrexate may have therapeutic potential in man.

Full text

PDF
229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett A., Berstock D. A., Carroll M. A. Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. Br J Cancer. 1982 May;45(5):762–768. doi: 10.1038/bjc.1982.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett A., Carroll M. A., Melhuish P. B., Stamford I. F. Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin. Br J Cancer. 1985 Aug;52(2):245–249. doi: 10.1038/bjc.1985.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett A., Charlier E. M., McDonald A. M., Simpson J. S., Stamford I. F., Zebro T. Prostaglandins and breast cancer. Lancet. 1977 Sep 24;2(8039):624–626. doi: 10.1016/s0140-6736(77)92496-5. [DOI] [PubMed] [Google Scholar]
  4. Bennett A., Houghton J., Leaper D. J., Stamford I. F. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins. 1979 Feb;17(2):179–191. doi: 10.1016/0090-6980(79)90037-6. [DOI] [PubMed] [Google Scholar]
  5. Berstock D. A., Houghton J., Bennett A. Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis. Cancer Treat Rev. 1979 Jun;6 (Suppl):69–71. doi: 10.1016/s0305-7372(79)80015-8. [DOI] [PubMed] [Google Scholar]
  6. Dixon R. L., Adamson R. H. Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878). Cancer Chemother Rep. 1965 Oct;48:11–16. [PubMed] [Google Scholar]
  7. Flores A. G., Sharp G. W. Endogenous prostaglandins and osmotic water flow in the toad bladder. Am J Physiol. 1972 Dec;223(6):1392–1397. doi: 10.1152/ajplegacy.1972.223.6.1392. [DOI] [PubMed] [Google Scholar]
  8. Gaffen J. D., Bennett A., Barer M. R. A new method for studying cell growth in suspension, and its use to show that indomethacin enhances cell killing by methotrexate. J Pharm Pharmacol. 1985 Apr;37(4):261–263. doi: 10.1111/j.2042-7158.1985.tb05056.x. [DOI] [PubMed] [Google Scholar]
  9. Henderson G. B., Zevely E. M., Huennekens F. M. Cyclic adenosine 3':5'-monophosphate and methotrexate transport in L1210 cells. Cancer Res. 1978 Mar;38(3):859–861. [PubMed] [Google Scholar]
  10. Hewitt H. B., Blake E. R., Walder A. S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976 Mar;33(3):241–259. doi: 10.1038/bjc.1976.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jolivet J., Cowan K. H., Curt G. A., Clendeninn N. J., Chabner B. A. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983 Nov 3;309(18):1094–1104. doi: 10.1056/NEJM198311033091805. [DOI] [PubMed] [Google Scholar]
  12. Lee E. T., Desu M. M. A computer program for comparing K samples with right-censored data. Comput Programs Biomed. 1972 Nov;2(4):315–321. doi: 10.1016/0010-468x(72)90019-0. [DOI] [PubMed] [Google Scholar]
  13. Murray J. G., MacIntyre J., Leiberman D. P., Leaper D. J. Toxicity of oral adjuvant chemotherapy in breast cancer. Br Med J. 1978 Feb 18;1(6110):408–409. doi: 10.1136/bmj.1.6110.408-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Northover B. J. Effect of anti-inflammatory drugs on the binding of calcium to cellular membranes in various human and guinea-pig tissues. Br J Pharmacol. 1973 Jul;48(3):496–504. doi: 10.1111/j.1476-5381.1973.tb08356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Powles T. J., Alexander P., Millar J. L. Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis. Biochem Pharmacol. 1978 May 1;27(9):1389–1392. doi: 10.1016/0006-2952(78)90127-2. [DOI] [PubMed] [Google Scholar]
  16. Tavares I. A., Capasso F., Vine N. D., Bennett A. Effects of isoxicam and other non-steroidal anti-inflammatory drugs on arachidonic acid metabolism by rat peritoneal leucocytes. J Pharm Pharmacol. 1985 Aug;37(8):587–588. doi: 10.1111/j.2042-7158.1985.tb03077.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES